A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children
- PMID: 27532370
- PMCID: PMC5215502
- DOI: 10.1080/21645515.2016.1216286
A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children
Abstract
Changing epidemiology of Hepatitis A virus (HAV) has led to an increased susceptibility of adolescents and adults to the infection. Vaccination can remarkably reduce the incidence and associated morbidity of HAV infection. This review is focused on the safety and efficacy of H2 strain derived live attenuated Hepatitis A vaccine. We found the vaccine to be highly immunogenic with minimal or negligible safety issues. Moreover, a single dose of live attenuated vaccine persists a long term immune response and can be a preferred option for developing countries. In 2014, Indian Academy of Paediatrics (IAP) also updated their recommendations for H2 vaccine as a single dose as against the previous 2 dose schedule. A focused approach to include the vaccine in national immunization program should be explored.
Keywords: Hepatitis A; immunogenicity; live attenuated vaccine; safety; seroconversion.
Figures
Similar articles
-
Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.Clin Microbiol Infect. 2016 Sep;22(9):811.e9-811.e15. doi: 10.1016/j.cmi.2016.06.004. Epub 2016 Jun 23. Clin Microbiol Infect. 2016. PMID: 27345175 Clinical Trial.
-
Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India.Hum Vaccin Immunother. 2025 Dec;21(1):2447643. doi: 10.1080/21645515.2024.2447643. Epub 2025 Jan 16. Hum Vaccin Immunother. 2025. PMID: 39819191 Free PMC article.
-
Immunogenicity of single dose live attenuated hepatitis a vaccine.Indian Pediatr. 2011 Feb;48(2):135-7. doi: 10.1007/s13312-011-0039-4. Epub 2010 Nov 30. Indian Pediatr. 2011. PMID: 21169655
-
Review of long term immunogenicity and tolerability of live hepatitis A vaccine.Hum Vaccin Immunother. 2020 Nov 1;16(11):2816-2821. doi: 10.1080/21645515.2020.1741997. Epub 2020 Apr 3. Hum Vaccin Immunother. 2020. PMID: 32243237 Free PMC article. Review.
-
Development, production, and postmarketing surveillance of hepatitis A vaccines in China.J Epidemiol. 2014;24(3):169-77. doi: 10.2188/jea.je20130022. Epub 2014 Mar 29. J Epidemiol. 2014. PMID: 24681843 Free PMC article. Review.
Cited by
-
Immunizations in Athletes.Sports Health. 2018 Sep/Oct;10(5):427-433. doi: 10.1177/1941738118788279. Epub 2018 Jul 30. Sports Health. 2018. PMID: 30059267 Free PMC article. Review.
-
The infectivity and pathogenicity of hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice.Virol Sin. 2022 Oct;37(5):740-745. doi: 10.1016/j.virs.2022.07.009. Epub 2022 Jul 19. Virol Sin. 2022. PMID: 35863604 Free PMC article.
-
Present and future management of viral hepatitis.World J Gastroenterol. 2021 Dec 21;27(47):8081-8102. doi: 10.3748/wjg.v27.i47.8081. World J Gastroenterol. 2021. PMID: 35068856 Free PMC article. Review.
-
Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.BMC Infect Dis. 2020 Aug 26;20(1):627. doi: 10.1186/s12879-020-05318-7. BMC Infect Dis. 2020. PMID: 32842988 Free PMC article.
-
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review.Viruses. 2023 Jan 12;15(1):214. doi: 10.3390/v15010214. Viruses. 2023. PMID: 36680254 Free PMC article. Review.
References
-
- Costa-Mattioli M, Di Napoli A, Ferre V, Billaudel S, Perez-Bercoff R, Cristina J. Genetic variability of hepatitis A virus. J Gen Virol 2003; 84:3191-201; PMID:14645901; http://dx.doi.org/10.1099/vir.0.19532-0 - DOI - PubMed
-
- Koff RS. Hepatitis A. Lancet 1998; 351:1643-9; PMID:9620732; http://dx.doi.org/10.1016/S0140-6736(98)01304-X - DOI - PubMed
-
- Hadler SC, McFarland L. Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis 1986; 8:548-57; PMID:3018889; http://dx.doi.org/10.1093/clinids/8.4.548 - DOI - PubMed
-
- Jacobsen KH. The global prevalence of Hepatitis A virus infection and susceptibility: a systematic review. 2010. Available at: http://apps.who.int/iris/bitstream/10665/70180/1/WHO_IVB_10.01_eng.pdf; Accessed on August 10, 2016.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials